Navigation Links
Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic Surgery Special Issue on Fillers
Date:6/26/2008

teven Basta, Chief Executive Officer of BioForm Medical. "With over 60 peer-reviewed publications in various prestigious journals, Radiesse dermal filler is one of the most rigorously studied materials in facial aesthetics. We thank the authors of these publications for sharing their results with the medical community."

A 52-Month Summary of Results Using Calcium Hydroxylapatite for Facial Soft Tissue Augmentation

This retrospective clinical review conducted by Thomas L. Tzikas, MD, documented the safety and effectiveness of Radiesse dermal filler in treatment of nasolabial folds, marionette lines, and other areas of the face. Over a 52 month period, from October 2002 to January 2007, Radiesse filler was injected in 1,000 patients (886 women and 114 men, ranging in age from 21 to 85 years) for a variety of facial aesthetic applications. The nasolabial folds were the most frequently treated site, followed by the marionette lines/oral commissures.

The clinical review found a high satisfaction rate with Radiesse dermal filler treatment, with most patients experiencing at least 80% persistence of effect at 1-year follow-up without retreatment, independent of the area of the face where treatment was received.

In conclusion, the author stated, "Radiesse was well tolerated over the 4 years of use described here. Adverse events were minor, and most resolved without treatment. No product-related serious adverse events were reported. Some patients experienced minor effects, such as redness, swelling, itching, and bruising, which are commonly seen with any injectable material, including collagen and hyaluronic acid."

The study abstract is available at http://www.blackwell-synergy.com/doi/abs/10.1111/j.1524-4725.2008.34237.x

An Investigation of Changes in Physical Properties of Injectable Calcium Hydroxylapatite in a Carrier Gel
'/>"/>

SOURCE BioForm Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
2. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
3. Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results
4. Non-Safety-Related Voluntary Recall of a Limited Portion of DAYTRANA(TM) (Methylphenidate Transdermal System) Patches Announced
5. Biologics, Derma Fillers are Key to Dermatological Drug Market Growth
6. Osteotechs Plexur P(TM) Receives FDA Clearance as Bone Void Filler and Bone Graft Extender in Spine
7. lifesDHA(TM) Featured in New Ricos(R) Cheese Sauce
8. Boydens Summit Practice Featured in the September Issue of New Jersey Business Magazine
9. Cheetah Medicals NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting
10. Synvista Therapeutics to be Featured on Wallst.net
11. Astex Drug Candidates to be Featured at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... This webinar will examine the history ... and review the basic FDA regulations and guiding ... these principles through real world case studies and ... on FDA regulations and guidance related to prescription ... traditional and newer forms of promotional materials for ...
(Date:6/18/2013)... , June 18, 2013   Lexicon Pharmaceuticals, ... biopharmaceutical company focused on discovering breakthrough treatments for ... has joined the company as its vice ... Northcott brings extensive commercial experience to Lexicon, including ... variety of therapeutic areas. Mr. Northcott ...
(Date:6/18/2013)... 18, 2013 Though health care jobs ... to the U.S. Bureau of Labor Statistics -- the increase ... per month. Most new health care jobs were added in ... saw a loss of 6,000 jobs. Overall, the U.S. unemployment ... Challenger, Gray & Christmas reported that a total of just ...
(Date:6/18/2013)... Woburn, MA (PRWEB) June 18, 2013 ... of an automated system for rapid bacterial strain ... M.B.A., has joined the company as Vice President ... and integration for the company’s RESOLUTION™ Microbial ... which includes the benchtop instrument, pathogen-specific assay kits, ...
Breaking Biology Technology:Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3
... WOODLANDS, Texas, Nov. 5, 2010 Lexicon Pharmaceuticals, ... company focused on discovering breakthrough treatments for human disease, ... and reported financial results for the three and nine ... established proof-of-concept for two new mechanisms of action in ...
... Patricia Thiel of Iowa State University and the Ames Laboratory ... coasters to the middle and a trinket box to the left. ... of little things." So Thiel grabbed the smaller things and slid ... "Nature wants one big thing all together, like this." Thiel, ...
... Science, Inc. (OTC Bulletin Board: CBIS ), ... announced today that regardless of the outcome of Proposition ... the country, it is apparent that that the Cannabis ... ever, as the demand for the Cannabis Science Pharmaceutical ...
Cached Biology Technology:Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 2Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 3Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 4Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 5Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 6Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 7Iowa State, Ames Laboratory scientists advance the understanding of the big getting bigger 2Proposition 19 Decision Prompts Cannabis Science to Anticipate Increased Demand for its Pharmaceutical Products for Critical Ailments and Begin the Formal Application Process for FDA Clinical Trials Immediately 2Proposition 19 Decision Prompts Cannabis Science to Anticipate Increased Demand for its Pharmaceutical Products for Critical Ailments and Begin the Formal Application Process for FDA Clinical Trials Immediately 3
(Date:6/18/2013)... at the University of Calgary,s Faculty of Medicine have ... body from harmful bacteria. Platelets, a component of blood ... for specific bacteria, and upon detection, seal it off ... were published in Nature Immunology this week, ... immunity. , "The science community has known that platelets ...
(Date:6/18/2013)... Research Council, Laboratory of Molecular Biology, has been ... Young Investigator Award. Torrent is being recognized for ... algorithm to predict antimicrobial regions in proteins. Luis ... now applying this algorithm to interrogate full genomes ... with very appealing results." , Torrent obtained ...
(Date:6/18/2013)... between 5% and 10% of breast and ovarian cancers ... these tumours are attributable to inherited mutations from the ... patients with these mutations, PARP inhibitors, which are currently ... them a new option for personalised cancer treatment, an ... that a fraction of these patients generate resistance to ...
Breaking Biology News(10 mins):Immunity mechanism discovered 2The American Society for Microbiology honors Marc Torrent 2An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2
... buy large quantities of anthrax, in a controversial move that ... designed to limit the spread of biological weapons. , A ... the US army' Dugway Proving Ground in Utah. They ask ... a non-virulent strain of anthrax, and for equipment to produce ...
... to the deadly skin cancer melanoma, studying functional ... insight into the disease's development, according to new ... fellow at Stanford University School of Medicine. , ... development, scientists have not been able to establish ...
... findings and statistically significant improvements in clinical measures ... on the Etiology, Pathogenesis and Treatment of Parkinson's ... showed positive interim results in patients with Parkinson's ... a statistically significant improvement in motor function on ...
Cached Biology News:US Army plans to bulk-buy anthrax 2Researchers use RNAi libraries to identify regulators of apoptosis and chemoresistance 2Researchers use RNAi libraries to identify regulators of apoptosis and chemoresistance 3Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 2Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 3Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 4Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 5Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 6
RECOMBINANT EQUINE IL-4 Product Type: Recombinant Protein...
RECOMBINANT EQUINE TNF ALPHA Product Type: Recombinant Protein...
Request Info...
Request Info...
Biology Products: